Orsini - Rare Disease Pharmacy Solutions

Orsini is proud to be a specialty pharmacy partner selected by Ascendis Pharma for Yorvipath (palopegteriparatide). “We’re thrilled to add YORVIPATH to our growing portfolio of endocrinology therapies,” Darin DeCarlo, Orsini’s Chief Growth Officer, said. “Orsini is built to serve rare disease patients, and we're excited to partner with Ascendis to deliver this new treatment option to patients suffering from chronic hypoparathyroidism.” Read the press release: https://bit.ly/3Vvdfv0 #PatientCare #RareDisease #NoPatientLeftBehind

🦃 Happy Thanksgiving! 🦃 Our pharmacy will be closed today as we give thanks and spend time with loved ones. Our dedicated clinicians are always on call for urgent needs. We'll reopen Friday morning, ready to serve our patients and partners with gratitude and care. Have a wonderful Thanksgiving!

Orsini is proud to be a specialty pharmacy partner selected by BridgeBio for Attruby (acoramidis), an orally administered treatment for cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM). “Orsini is deeply embedded in the cardiomyopathy space, having supported patients suffering from the disorder for over five years,” Darin DeCarlo, Orsini’s Chief Growth Officer, said. “Our partnership with BridgeBio offers us a tremendous opportunity to bring new hope to the patients we serve.” Read the press release: https://lnkd.in/eedd4GE7 #ATTRCM #PatientCare #RareDisease #NoPatientLeftBehind

Leading the Way in Cell & Gene Therapy At Orsini, we’re proud to be the leading independent specialty pharmacy dispensing cell and gene therapies (CAGT). With 6 launched therapies—and more on the horizon—we’re dedicated to ensuring patients have access to these life-changing treatments. From navigating patient access challenges and managing ultra-cold chain logistics to providing exceptional support for treatment centers, Orsini is committed to advancing innovation and outcomes for patients receiving CAGT treatment. Watch this video to learn more about how our team supports the treatment journey: https://bit.ly/3YXTHAq #CellAndGeneTherapy #CAGT #CGT #SpecialtyPharmacy #RareDisease #NoPatientLeftBehind

We are proud to share that Vertex Pharmaceuticals has chosen Orsini to dispense gene-editing therapy CASGEVY® (exagamglogene autotemcel). Read the full press release here: https://bit.ly/4hBAvkz #NoPatientLeftBehind #CRISPR #CAGT #CGT

https://lnkd.in/giWywhSX

Today, we honor and express our deepest gratitude to veterans who have served and sacrificed for our country. To all veterans, we thank you for your service. We are committed to serving you with the same dedication and respect you've shown to our country. #VeteransDay #ThankYouVeterans #OrsiniCares

“It’s been Orsini’s honor to offer care to hereditary angioedema (HAE) patients and their families for over 13 years, and our team is very familiar with the unique needs and difficulties that they face every day,” Brandon Tom, Orsini’s CEO, said. “We’re excited to partner with Cycle Pharmaceuticals to add SAJAZIR to our portfolio, further enhancing our ability to serve the HAE community.” Read the full press release here: https://bit.ly/4hzKR4r #specialtypharmacy #patientcare #NoPatientLeftBehind #HAE

We’re excited to participate in this week's Specialty Networks & Patient Support Services Summit hosted by The Healthcare Innovation Company (thINc). If you're attending, don’t miss Orsini's Nick Calla on the panel: "Managing the Rare Disease Patient Experience Amidst the Gene Therapy Revolution." #ThincSummit #SpecialtyPharmacy #RareDiseaseCare

October is National Niemann-Pick Disease Awareness Month 💜 At Orsini, we're committed to supporting patients affected by Niemann-Pick disease, a rare and life-threatening genetic condition. We are proud to work closely with healthcare providers, caregivers, and pharmaceutical partners to ensure access to life-changing therapies for Niemann-Pick patients. Together, we can make a difference in the lives of those impacted by Niemann-Pick disease. Learn more about the support we provide through our Genetics Center of Excellence: https://bit.ly/3zUHELU #NiemannPickAwareness #NPCAwareness #RareDiseaseSupport #PatientCare #OrsiniCares #NoPatientLeftBehind